Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU)

PLoS One. 2018 Feb 5;13(2):e0191837. doi: 10.1371/journal.pone.0191837. eCollection 2018.

Abstract

Mucosal-associated invariant T (MAIT) cells are an abundant class of innate T cells restricted by the MHC I-related molecule MR1. MAIT cells can recognize bacterially-derived metabolic intermediates from the riboflavin pathway presented by MR1 and are postulated to play a role in innate antibacterial immunity through production of cytokines and direct bacterial killing. MR1 tetramers, typically stabilized by the adduct of 5-amino-6-D-ribitylaminouracil (5-A-RU) and methylglyoxal (MeG), are important tools for the study of MAIT cells. A long-standing problem with 5-A-RU is that it is unstable upon storage. Herein we report an efficient synthetic approach to the HCl salt of this ligand, which has improved stability during storage. We also show that synthetic 5-A-RU•HCl produced by this method may be used in protocols for the stimulation of human MAIT cells and production of both human and mouse MR1 tetramers for MAIT cell identification.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Histocompatibility Antigens Class I / metabolism*
  • Humans
  • Immunity, Innate
  • Ligands
  • Minor Histocompatibility Antigens / metabolism*
  • Mucosal-Associated Invariant T Cells / immunology
  • Ribitol / analogs & derivatives*
  • Ribitol / chemical synthesis
  • Ribitol / metabolism
  • Uracil / analogs & derivatives*
  • Uracil / chemical synthesis
  • Uracil / metabolism

Substances

  • 5-amino-6-D-ribitylaminouracil
  • Histocompatibility Antigens Class I
  • Ligands
  • MR1 protein, human
  • Minor Histocompatibility Antigens
  • Ribitol
  • Uracil